|

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

RECRUITINGEarly 1Sponsored by Anna Stanhewicz, PhD
Actively Recruiting
PhaseEarly 1
SponsorAnna Stanhewicz, PhD
Started2023-08-30
Est. completion2027-06-30
Eligibility
Age18 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this investigation is to examine NADPH oxidase as a source of reactive oxygen species contributing to aberrant microvascular function in otherwise healthy women with a history of GDM.

Eligibility

Age: 18 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
INCLUSION CRITERIA:

* 18 years or older
* pregnant within 5 years of the study visit
* had gestational diabetes diagnosed by their obstetrician and confirmed according to the American College of Obstetricians and Gynecologists criteria for gestational diabetes.
* or without a history of gestational diabetes

EXCLUSION CRITERIA:

* skin diseases
* current tobacco or electronic cigarette/vape pen use,
* diagnosed or suspected hepatic or metabolic disease including diabetes,
* statin or other cholesterol-lowering medication,
* current antihypertensive medication,
* history of preeclampsia or gestational hypertension,
* current pregnancy,
* body mass index \<18.5 kg/m2,
* allergy to materials used during the experiment.(e.g. latex),
* known allergies to study drugs

Conditions4

DiabetesGestational DiabetesOxidative StressVascular Endothelial Function

Locations1 site

University of Iowa
Iowa City, Iowa, 52242
Anna Stanhewicz, PhD319-467-1732anna-stanhewicz@uiowa.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.